Home > Healthcare > Medical Devices > Medical Supplies > U.S. Cancer Contrast Media Market

U.S. Cancer Contrast Media Market Size

Report ID: GMI8339
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

U.S. Cancer Contrast Media Market Size

U.S. Cancer Contrast Media Market size was valued at USD 2.4 billion in 2023 and is estimated to grow at a CAGR of 4.9% between 2024 and 2032. Cancer contrast media refers to specialized contrast agents or dyes used in medical imaging procedures specifically aimed at diagnosing, staging, or monitoring cancer. These contrast media are designed to enhance the visualization of cancerous tissues, tumors, and associated structures during imaging studies such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound.

To get key market trends

Download Free Sample

The increasing prevalence of cancer cases has emerged as a significant driver for the market. For instance, according to the American Cancer Society in 2021, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the U.S. Therefore, there is a rising need for effective treatments such as chemotherapy, radiation therapy, immunotherapy to address the complexities of managing cancer-related issues.

U.S. Cancer Contrast Media Market Report Attributes
Report Attribute	Details
Base Year:	2023
U.S. Cancer Contrast Media Market Size in 2023:	USD 2.4 Billion
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	4.9%
2032 Value Projection:	USD 3.7 Billion
Historical Data for:	2018 – 2023
No. of Pages:	181
Tables, Charts & Figures:	284
Segments covered:	Product Type, Modality, Application and End-use
Growth Drivers:	Increasing number of clinical studies Rising prevalence of cancer cases Technological advancements in cancer contrast imaging
Pitfalls & Challenges:	Side effects and adverse reactions related to contrast agents Presence of alternative imaging options

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, growing technological advancements in cancer contrast imaging such as MRI contrast media, which is set to reach USD 2.5 billion by 2032, increasing number of clinical studies, among other contributing factors are anticipated to propel the industry growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of U.S. cancer contrast media reached USD 2.4 billion in 2023 and is set to witness 4.9% CAGR during 2024 to 2032, propelled by the increasing prevalence of cancer coupled with the growing technological advancements.

The CT scan segment is projected to account for USD 1.2 billion in revenue by 2032, owing to its increasing use for monitoring the response to cancer treatment longitudinally and getting detailed insights into treatment efficacy and progression.

U.S. cancer contrast media industry from breast cancer application segment accounted for 24.1% revenue share in 2023, due to the rising prevalence of breast cancer in the U.S.

Some of the top cancer contrast media companies in the U.S. include Bayer AG, Bracco Imaging S.p.A., GE Healthcare Technologies Inc, Guerbet, iMAX Diagnostic Imaging, Lantheus Medical Imaging, nanoPET Pharma GmbH, Subtle Medical, Inc., Telix Pharmaceuticals Limited, and Trivitron Healthcare.